反応式
C([Li])CCC.[N:6]1[C:11]2[NH:12][C:13]3[CH:21]=[CH:20][CH:19]=[CH:18][C:14]=3[C:15](=[O:17])[NH:16][C:10]=2[CH:9]=[CH:8][CH:7]=1.[C:22](Cl)(=[O:27])[CH2:23][CH2:24][C:25]#[CH:26]>CCCCCC.O1CCCC1.C(OCC)(=O)C>[O:27]=[C:22]([N:12]1[C:13]2[CH:21]=[CH:20][CH:19]=[CH:18][C:14]=2[C:15](=[O:17])[NH:16][C:10]2[CH:9]=[CH:8][CH:7]=[N:6][C:11]1=2)[CH2:23][CH2:24][C:25]#[CH:26]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 3
反応条件
- 温度
- 30 °C
実験手順
22.4 ml of a 1.6 molar solution of n-butyl-lithium in n-hexane are added dropwise with stirring, at 0° C., to a suspension of 3.7 g (0.017 mol) of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one in 150 ml of absolute tetrahydrofuran. After it has all been added, the mixture is stirred for a further 30 minutes and then mixed with a solution of 2.04 g (0.0175 mol) of 4-pentynoic acid chloride in 20 ml of tetrahydrofuran. The mixture is heated to 30° C. and stirred for a further hour. The reaction mixture is then poured into a saturated saline solution. The organic phase is diluted with ethyl acetate and, after being separated off, washed twice with saline solution, filtered over charcoal and evaporated to dryness in vacuo. The crude product is purified by column chromatography on silica gel using chloroform as eluant. 2.2 g (43% of theory) of colourless crystals were obtained, melting point 179°-180° C.
後処理
- additionall been added
- stirringstirred for a further hour
- additionThe reaction mixture is then poured into a saturated saline solution
- customafter being separated off
- washwashed twice with saline solution
- filtrationfiltered over charcoal
- customevaporated to dryness in vacuo
- customThe crude product is purified by column chromatography on silica gel
- custom2.2 g (43% of theory) of colourless crystals were obtained
出典と根拠
- ORDレコード
- ord-74fbee929e784564bd98215859d583b0
- 出典データセット
- uspto-grants-1988_02
- 特許番号
- US04724236
関連ノート
読み込み中…